DT’s Q4 results were largely in line with estimates as revenue declined by 6% y/y while EBITA was down EUR 1.5m to EUR 3.7m. Security applications declined even more than we estimated while medical was clearly stronger, leading DT’s figures very close to our estimates. DT expects to see double-digit growth over H1’26, as previously indicated.
LÄS MER
